Raras
Buscar doenças, sintomas, genes...
Síndrome Marfan e doenças Marfan-relacionadas
ORPHA:284993DOENÇA RARA

O fator de crescimento transformador beta é uma citocina multifuncional pertencente à superfamília do fator de crescimento transformador que inclui três isoformas diferentes de mamíferos e muitas outras proteínas de sinalização. As proteínas TGFB são produzidas por todas as linhagens de glóbulos brancos. Essa proteína que controla a proliferação, diferenciação celular e outras funções na maioria das células. Ela desempenha um papel na imunidade, câncer, doenças cardíacas, diabetes e síndrome de Marfan. TGF-beta atua como um fator antiproliferativo em células epiteliais normais e em estágios iniciais da oncogênese.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Síndrome Marfan e doenças relacionadas são distúrbios genéticos do tecido conjuntivo que afetam múltiplos sistemas, incluindo cardiovascular, esquelético e ocular. Podem causar aneurismas da aorta, problemas nas válvulas cardíacas, escoliose, aracnodactilia e alterações oculares como megalocórnea.

Medicamentos
10 registrados
PERINDOPRIL, ALISKIREN, LOSARTAN

Tem tratamento?

10 medicamentos registrados
Ver detalhes, fases e interações →
PERINDOPRILALISKIRENLOSARTANNEBIVOLOLATENOLOLLOSARTAN POTASSIUMDOXYCYCLINEDOXYCYCLINE ANHYDROUSIRBESARTANPROPRANOLOL
🏥
SUS: Cobertura mínimaScore: 20%
Centros em: PA, PR, SC, RS, ES +10
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
51 sintomas
❤️
Coração
37 sintomas
😀
Face
28 sintomas
💪
Músculos
20 sintomas
👁️
Olhos
11 sintomas
🧠
Neurológico
11 sintomas

+ 111 sintomas em outras categorias

Características mais comuns

Espondilolistese
Hiporreflexia
Ponte nasal ampla
Morfologia anormal da bexiga
Cefaleia
Dedo do pé longo
313sintomas
Sem dados (313)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 313 características clínicas mais associadas, ordenadas por frequência.

EspondilolisteseSpondylolisthesis
HiporreflexiaHyporeflexia
Ponte nasal amplaWide nasal bridge
Morfologia anormal da bexigaAbnormality of bladder morphology
CefaleiaHeadache

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa11
Últimos 10 anos10publicações
Pico20152 papers
Linha do tempo
20202015Hoje · 2026🧪 2008Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

10 genes identificados com associação a esta condição.

TGFBR1TGF-beta receptor type-1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transmembrane serine/threonine kinase forming with the TGF-beta type II serine/threonine kinase receptor, TGFBR2, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing,

LOCALIZAÇÃO

Cell membraneCell junction, tight junctionCell surfaceMembrane raft

VIAS BIOLÓGICAS (6)
TGF-beta receptor signaling activates SMADsTGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)Downregulation of TGF-beta receptor signalingTGFBR2 Kinase Domain Mutants in CancerTGFBR3 regulates TGF-beta signaling
MECANISMO DE DOENÇA

Loeys-Dietz syndrome 1

An aortic aneurysm syndrome with widespread systemic involvement, characterized by arterial tortuosity and aneurysms, hypertelorism, and bifid uvula or cleft palate. Physical findings include prominent joint laxity, easy bruising, wide and atrophic scars, velvety and translucent skin with easily visible veins, spontaneous rupture of the spleen or bowel, and catastrophic complications of pregnancy, including rupture of the gravid uterus and the arteries, either during pregnancy or in the immediate postpartum period. Some patients have craniosynostosis, exotropy, micrognathia and retrognathia, structural brain abnormalities, and intellectual deficit.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
47.9 TPM
Artéria tibial
37.9 TPM
Artéria coronária
35.2 TPM
Cólon sigmoide
31.9 TPM
Fibroblastos
28.0 TPM
OUTRAS DOENÇAS (5)
Loeys-Dietz syndrome 1multiple self-healing squamous epitheliomaLoeys-Dietz syndrome 2Loeys-Dietz syndrome
HGNC:11772UniProt:P36897
IPO8Importin-8Candidate gene tested inRestrito
FUNÇÃO

Involved in nuclear protein import, either by acting as autonomous nuclear transport receptor or as an adapter-like protein in association with the importin-beta subunit KPNB1. Acting autonomously, may serve as receptor for nuclear localization signals (NLS) and promote translocation of import substrates through the nuclear pore complex (NPC) by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to importin, the importin/substrate complex dissociates an

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (1)
Transcriptional regulation by small RNAs
MECANISMO DE DOENÇA

VISS syndrome

An autosomal recessive disease characterized by early-onset thoracic aortic aneurysm, aneurysm and tortuosity of other arteries, motor developmental delay, connective tissue findings such as joint hypermobility, skin laxity and hernias, and craniofacial dysmorphic features. Immune dysregulation has been reported in some patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
33.7 TPM
Nervo tibial
32.7 TPM
Útero
32.6 TPM
Cervix Endocervix
29.0 TPM
Fibroblastos
28.2 TPM
OUTRAS DOENÇAS (2)
VISS syndromeLoeys-Dietz syndrome
HGNC:9853UniProt:O15397
FBN1Fibrillin-1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Structural component of the 10-12 nm diameter microfibrils of the extracellular matrix, which conveys both structural and regulatory properties to load-bearing connective tissues (PubMed:15062093, PubMed:1860873). Fibrillin-1-containing microfibrils provide long-term force bearing structural support (PubMed:27026396). In tissues such as the lung, blood vessels and skin, microfibrils form the periphery of the elastic fiber, acting as a scaffold for the deposition of elastin (PubMed:27026396). In

LOCALIZAÇÃO

SecretedSecreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (2)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
MECANISMO DE DOENÇA

Marfan syndrome

A hereditary disorder of connective tissue that affects the skeletal, ocular, and cardiovascular systems. A wide variety of skeletal abnormalities occurs with Marfan syndrome, including scoliosis, chest wall deformity, tall stature, abnormal joint mobility. Ectopia lentis occurs in most of the patients and is almost always bilateral. The leading cause of premature death is progressive dilation of the aortic root and ascending aorta, causing aortic incompetence and dissection. Neonatal Marfan syndrome is the most severe form resulting in death from cardiorespiratory failure in the first few years of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
295.9 TPM
Artéria coronária
63.8 TPM
Aorta
63.1 TPM
Tecido adiposo
54.3 TPM
Esôfago - Junção
48.0 TPM
OUTRAS DOENÇAS (14)
geleophysic dysplasia 2Weill-Marchesani syndrome 2, dominantMASS syndromeectopia lentis 1, isolated, autosomal dominant
HGNC:3603UniProt:P35555
FBN2Fibrillin-2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Fibrillins are structural components of 10-12 nm extracellular calcium-binding microfibrils, which occur either in association with elastin or in elastin-free bundles. Fibrillin-2-containing microfibrils regulate the early process of elastic fiber assembly. Regulates osteoblast maturation by controlling TGF-beta bioavailability and calibrating TGF-beta and BMP levels, respectively Hormone secreted by trophoblasts that promotes trophoblast invasiveness (PubMed:32329225). Has glucogenic activity:

LOCALIZAÇÃO

SecretedSecreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
Elastic fibre formation
MECANISMO DE DOENÇA

Contractural arachnodactyly, congenital

An autosomal dominant connective tissue disorder characterized by contractures, arachnodactyly, scoliosis, and crumpled ears.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fibroblastos
126.7 TPM
Testículo
6.0 TPM
Glândula adrenal
5.0 TPM
Esôfago - Muscular
2.9 TPM
Coração - Ventrículo esquerdo
2.7 TPM
OUTRAS DOENÇAS (2)
macular degeneration, early-onsetcongenital contractural arachnodactyly
HGNC:3604UniProt:P35556
TGFB3Transforming growth factor beta-3 proproteinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transforming growth factor beta-3 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-3 (TGF-beta-3) chains, which constitute the regulatory and active subunit of TGF-beta-3, respectively Required to maintain the Transforming growth factor beta-3 (TGF-beta-3) chain in a latent state during storage in extracellular matrix (By similarity). Associates non-covalently with TGF-beta-3 and regulates its activation via interaction with 'milieu molecules', su

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrixSecreted

VIAS BIOLÓGICAS (4)
Molecules associated with elastic fibresTGF-beta receptor signaling activates SMADsPlatelet degranulation ECM proteoglycans
MECANISMO DE DOENÇA

Arrhythmogenic right ventricular dysplasia, familial, 1

A congenital heart disease characterized by infiltration of adipose and fibrous tissue into the right ventricle and loss of myocardial cells, resulting in ventricular and supraventricular arrhythmias.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
77.8 TPM
Próstata
67.8 TPM
Cervix Ectocervix
57.8 TPM
Útero
46.5 TPM
Aorta
40.5 TPM
OUTRAS DOENÇAS (7)
Rienhoff syndromearrhythmogenic right ventricular dysplasia 1familial isolated arrhythmogenic ventricular dysplasia, right dominant formLoeys-Dietz syndrome
HGNC:11769UniProt:P10600
SMAD2SMAD family member 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD2/SMAD4 complex, activates transcription. Promotes TGFB1-mediated transcription of odontoblastic differentiation genes in dental papilla cells (By similarity). Positively regulates PDPK1

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (7)
TGF-beta receptor signaling activates SMADsSignaling by ActivinSignaling by NODALDownregulation of SMAD2/3:SMAD4 transcriptional activityDownregulation of TGF-beta receptor signaling
MECANISMO DE DOENÇA

Congenital heart defects, multiple types, 8, with or without heterotaxy

An autosomal dominant disorder characterized by congenital developmental abnormalities involving structures of the heart. Common CHTD8 features include double-outlet right ventricle, unbalanced complete atrioventricular canal, and valvular anomalies. Vascular anomalies include dextroposition of the great arteries, anomalous pulmonary venous return, and superior vena cava to left atrium defect. Patients may also exhibit laterality defects, including dextrocardia, atrial isomerism, dextrogastria, left-sided gallbladder, and intestinal malrotation.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
9.3 TPM
Nervo tibial
8.0 TPM
Artéria tibial
6.8 TPM
Ovário
6.8 TPM
Linfócitos
6.7 TPM
OUTRAS DOENÇAS (4)
Loeys-Dietz syndrome 6congenital heart defects, multiple types, 8, with or without heterotaxyfamilial thoracic aortic aneurysm and aortic dissectionLoeys-Dietz syndrome
HGNC:6768UniProt:Q15796
SMAD3SMAD family member 3Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD3/SMAD4 complex, activates transcription. Also can form a SMAD3/SMAD4/JUN/FOS complex at the AP-1/SMAD site to regulate TGF-beta-mediated transcription. Has an inhibitory effect on wound

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (9)
TGF-beta receptor signaling activates SMADsSignaling by ActivinSignaling by NODALDownregulation of SMAD2/3:SMAD4 transcriptional activityDownregulation of TGF-beta receptor signaling
MECANISMO DE DOENÇA

Colorectal cancer

A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Ectocervix
59.9 TPM
Fibroblastos
58.8 TPM
Tireoide
58.3 TPM
Cervix Endocervix
55.2 TPM
Vagina
50.3 TPM
OUTRAS DOENÇAS (3)
aneurysm-osteoarthritis syndromefamilial thoracic aortic aneurysm and aortic dissectionLoeys-Dietz syndrome
HGNC:6769UniProt:P84022
TGFBR2TGF-beta receptor type-2Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and thus regulates a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extr

LOCALIZAÇÃO

Cell membraneMembrane raftSecreted

VIAS BIOLÓGICAS (8)
TGF-beta receptor signaling activates SMADsDownregulation of TGF-beta receptor signalingUCH proteinasesTGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)TGFBR1 LBD Mutants in Cancer
MECANISMO DE DOENÇA

Hereditary non-polyposis colorectal cancer 6

An autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, HNPCC is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical HNPCC is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected HNPCC' or 'incomplete HNPCC' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
377.2 TPM
Tecido adiposo
319.8 TPM
Adipose Visceral Omentum
301.0 TPM
Mama
271.8 TPM
Nervo tibial
261.1 TPM
OUTRAS DOENÇAS (7)
Loeys-Dietz syndrome 2esophageal cancercolorectal cancer, hereditary nonpolyposis, type 6familial thoracic aortic aneurysm and aortic dissection
HGNC:11773UniProt:P37173
TGFB2Transforming growth factor beta-2 proproteinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-2 (TGF-beta-2) chains, which constitute the regulatory and active subunit of TGF-beta-2, respectively Required to maintain the Transforming growth factor beta-2 (TGF-beta-2) chain in a latent state during storage in extracellular matrix (By similarity). Associates non-covalently with TGF-beta-2 and regulates its activation via interaction with 'milieu molecules', such as LTBP1 and LRRC32/GARP, that control acti

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrixSecreted

VIAS BIOLÓGICAS (5)
TGF-beta receptor signaling activates SMADsTGFBR3 regulates TGF-beta signalingMolecules associated with elastic fibresPlatelet degranulation ECM proteoglycans
EXPRESSÃO TECIDUAL(Ubíquo)
Glândula salivar
15.0 TPM
Cervix Ectocervix
14.9 TPM
Cervix Endocervix
12.3 TPM
Próstata
10.2 TPM
Aorta
7.7 TPM
OUTRAS DOENÇAS (4)
Loeys-Dietz syndrome 4Camurati-Engelmann disease, type 2familial thoracic aortic aneurysm and aortic dissectionLoeys-Dietz syndrome
HGNC:11768UniProt:P61812
SKISki oncogeneDisease-causing germline mutation(s) inRestrito
FUNÇÃO

May play a role in terminal differentiation of skeletal muscle cells but not in the determination of cells to the myogenic lineage. Functions as a repressor of TGF-beta signaling

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
Downregulation of SMAD2/3:SMAD4 transcriptional activitySignaling by BMP
MECANISMO DE DOENÇA

Shprintzen-Goldberg craniosynostosis syndrome

A very rare syndrome characterized by a marfanoid habitus, craniosynostosis, characteristic dysmorphic facial features, skeletal and cardiovascular abnormalities, intellectual disability, developmental delay and learning disabilities.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
235.4 TPM
Cerebelo
233.1 TPM
Artéria tibial
154.4 TPM
Aorta
150.9 TPM
Útero
107.2 TPM
OUTRAS DOENÇAS (2)
Shprintzen-Goldberg syndromechromosome 1p36 deletion syndrome
HGNC:10896UniProt:P12755

Medicamentos e terapias

PERINDOPRILPhase 3

Mecanismo: Angiotensin-converting enzyme inhibitor

ALISKIRENPhase 3

Mecanismo: Renin inhibitor

LOSARTANPhase 3

Mecanismo: Type-1 angiotensin II receptor antagonist

NEBIVOLOLPhase 3

Mecanismo: Beta-2 adrenergic receptor antagonist

ATENOLOLPhase 3

Mecanismo: Beta-1 adrenergic receptor antagonist

LOSARTAN POTASSIUMPhase 3

Mecanismo: Type-1 angiotensin II receptor antagonist

DOXYCYCLINEPhase 2

Mecanismo: Matrix metalloproteinase-1 inhibitor

DOXYCYCLINE ANHYDROUSPhase 2

Mecanismo: Matrix metalloproteinase 7 inhibitor

IRBESARTANPhase 2

Mecanismo: Type-1 angiotensin II receptor antagonist

PROPRANOLOLPhase 2

Mecanismo: Beta-2 adrenergic receptor antagonist

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

5,379 variantes patogênicas registradas no ClinVar.

🧬 TGFBR1: NM_004612.4(TGFBR1):c.1361T>C (p.Ile454Thr) ()
🧬 TGFBR1: NM_004612.4(TGFBR1):c.707C>G (p.Ser236Cys) ()
🧬 TGFBR1: NM_004612.4(TGFBR1):c.575-1G>A ()
🧬 TGFBR1: NM_004612.4(TGFBR1):c.884dup (p.Tyr295Ter) ()
🧬 TGFBR1: NM_004612.4(TGFBR1):c.1226G>A (p.Trp409Ter) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

39 vias biológicas associadas aos genes desta condição.

Downregulation of TGF-beta receptor signaling TGF-beta receptor signaling activates SMADs TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) SMAD2/3 Phosphorylation Motif Mutants in Cancer TGFBR2 Kinase Domain Mutants in Cancer TGFBR1 KD Mutants in Cancer TGFBR1 LBD Mutants in Cancer UCH proteinases Ub-specific processing proteases TGFBR3 regulates TGF-beta signaling Transcriptional regulation by small RNAs Degradation of the extracellular matrix Elastic fibre formation Molecules associated with elastic fibres Integrin cell surface interactions Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) Post-translational protein phosphorylation Platelet degranulation ECM proteoglycans Signaling by NODAL Signaling by Activin Downregulation of SMAD2/3:SMAD4 transcriptional activity SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription SMAD4 MH2 Domain Mutants in Cancer SMAD2/3 MH2 Domain Mutants in Cancer Transcriptional regulation of pluripotent stem cells FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes FOXO-mediated transcription of cell cycle genes Germ layer formation at gastrulation Formation of axial mesoderm Formation of definitive endoderm RUNX3 regulates CDKN1A transcription RUNX3 regulates BCL2L11 (BIM) transcription Interleukin-37 signaling NOTCH4 Intracellular Domain Regulates Transcription SARS-CoV-1 targets host intracellular signalling and regulatory pathways TGFBR3 expression TGFBR2 MSI Frameshift Mutants in Cancer Signaling by BMP

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 36
2Fase 24
Medicamentos catalogadosEnsaios clínicos· 10 medicamentos · 0 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome Marfan e doenças Marfan-relacionadas

Centros de Referência SUS

24 centros habilitados pelo SUS para Síndrome Marfan e doenças Marfan-relacionadas

Centros para Síndrome Marfan e doenças Marfan-relacionadas

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Universitário da UFJF

R. Catulo Breviglieri, Bairro - s/n - Santa Catarina, Juiz de Fora - MG, 36036-110 · CNES 2297442

Atenção Especializada

Rota
Anomalias Congênitas

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Julio Müller (HUJM)

R. Luis Philippe Pereira Leite, s/n - Alvorada, Cuiabá - MT, 78048-902 · CNES 2726092

Atenção Especializada

Rota
Anomalias Congênitas

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Lauro Wanderley (HULW)

R. Tabeliao Estanislau Eloy, 585 - Castelo Branco, João Pessoa - PB, 58050-585 · CNES 0002470

Atenção Especializada

Rota
Anomalias Congênitas

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital Universitário Regional de Maringá (HUM)

Av. Mandacaru, 1590 - Parque das Laranjeiras, Maringá - PR, 87083-240 · CNES 2216108

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Base de São José do Rio Preto

Av. Brg. Faria Lima, 5544 - Vila Sao Jose, São José do Rio Preto - SP, 15090-000 · CNES 2079798

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Aortic dissection during the perinatal period in women with Marfan-related disorders: a retrospective cohort study using the Japanese Diagnosis Procedure Combination database.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians2026 Dec

Women with Marfan-related disorders face an elevated risk of aortic dissection during pregnancy and the postpartum period. This study aimed to investigate the incidence of aortic dissection during the perinatal period in women with Marfan-related disorders. This retrospective cohort study analyzed data extracted from the Japanese Diagnosis Procedure Combination, a nationwide administrative claims database. We included women diagnosed with Marfan-related disorders (Marfan syndrome, Loeys-Dietz syndrome, or Ehlers-Danlos syndrome) who delivered between 2010 and 2023. We assessed the incidence of aortic dissection during pregnancy or postpartum hospitalization, and the incidence of re-hospitalization for aortic dissection. Moreover, we described the use of cabergoline and the incidence of aortic dissection. During the study period, we identified a total of 226 deliveries by 175 women with Marfan-related disorders. Cesarean section accounted for 69.0% of deliveries. During pregnancy, 1.8% of cases (4/226) experienced aortic dissection and required aortic surgery. In the postpartum period, 2.7% of cases (6/226) experienced aortic dissection during postpartum hospitalization. Within 1 year after delivery, 2.7% of cases (6/226) underwent re-hospitalization for aortic dissection. Cabergoline was administered for elective avoidance of breastfeeding within 2 days postpartum in 15 (6.6%) cases. The incidence of postpartum aortic dissection did not differ significantly between cabergoline users and non-users. Women with Marfan-related disorders may remain at risk of developing aortic dissection for up to 1 year postpartum.

#2

Targeted next-generation sequencing reveals the genetic mechanism of Chinese Marfan syndrome cohort with ocular manifestation.

Molecular genetics & genomic medicine2024 Jul

Marfan syndrome (MFS) is a hereditary connective tissue disorder involving multiple systems, including ophthalmologic abnormalities. Most cases are due to heterozygous mutations in the fibrillin-1 gene (FBN1). Other associated genes include LTBP2, MYH11, MYLK, and SLC2A10. There is significant clinical overlap between MFS and other Marfan-like disorders. To expand the mutation spectrum of FBN1 gene and validate the pathogenicity of Marfan-related genes in patients with MFS and ocular manifestations. We recruited 318 participants (195 cases, 123 controls), including 59 sporadic cases and 88 families. All patients had comprehensive ophthalmic examinations showing ocular features of MFS and met Ghent criteria. Additionally, 754 cases with other eye diseases were recruited. Panel-based next-generation sequencing (NGS) screened mutations in 792 genes related to inherited eye diseases. We detected 181 mutations with an 84.7% detection rate in sporadic cases and 87.5% in familial cases. The overall detection rate was 86.4%, with FBN1 accounting for 74.8%. In cases without FBN1 mutations, 23 mutations from seven Marfan-related genes were identified, including four pathogenic or likely pathogenic mutations in LTBP2. The 181 mutations included 165 missenses, 10 splicings, three frameshifts, and three nonsenses. FBN1 accounted for 53.0% of mutations. The most prevalent pathogenic mutation was FBN1 c.4096G>A. Additionally, 94 novel mutations were detected, with 13 de novo mutations in 14 families. We expanded the mutation spectrum of the FBN1 gene and provided evidence for the pathogenicity of other Marfan-related genes. Variants in LTBP2 may contribute to the ocular manifestations in MFS, underscoring its role in phenotypic diversity.

#3

Three-dimensional co-culturing of stem cell-derived cardiomyocytes and cardiac fibroblasts reveals a role for both cell types in Marfan-related cardiomyopathy.

Matrix biology : journal of the International Society for Matrix Biology2024 Feb

Pathogenic variants in the FBN1 gene, which encodes the extracellular matrix protein fibrillin-1, cause Marfan syndrome (MFS), which affects multiple organ systems, including the cardiovascular system. Myocardial dysfunction has been observed in a subset of patients with MFS and in several MFS mouse models. However, there is limited understanding of the intrinsic consequences of FBN1 variants on cardiomyocytes (CMs). To elucidate the CM-specific contribution in Marfan's cardiomyopathy, cardiosphere cultures of CMs and cardiac fibroblasts (CFs) are used. CMs and CFs were derived by human induced pluripotent stem cell (iPSC) differentiation from MFS iPSCs with a pathogenic variant in FBN1 (c.3725G>A; p.Cys1242Tyr) and the corresponding CRISPR-corrected iPSC line (Cor). Cardiospheres containing MFS CMs show decreased FBN1, COL1A2 and GJA1 expression. MFS CMs cultured in cardiospheres have fewer binucleated CMs in comparison with Cor CMs. 13% of MFS CMs in cardiospheres are binucleated and 15% and 16% in cardiospheres that contain co-cultures with respectively MFS CFs and Cor CFs, compared to Cor CMs, that revealed up to 23% binucleation when co-cultured with CFs. The sarcomere length of CMs, as a marker of development, is significantly increased in MFS CMs interacting with Cor CF or MFS CF, as compared to monocultured MFS CMs. Nuclear blebbing was significantly more frequent in MFS CFs, which correlated with increased stiffness of the nuclear area compared to Cor CFs. Our cardiosphere model for Marfan-related cardiomyopathy identified a contribution of CFs in Marfan-related cardiomyopathy and suggests that abnormal early development of CMs may play a role in the disease mechanism.

#4

Mutations in SKI in Shprintzen-Goldberg syndrome lead to attenuated TGF-β responses through SKI stabilization.

eLife2021 Jan 08

Shprintzen-Goldberg syndrome (SGS) is a multisystemic connective tissue disorder, with considerable clinical overlap with Marfan and Loeys-Dietz syndromes. These syndromes have commonly been associated with enhanced TGF-β signaling. In SGS patients, heterozygous point mutations have been mapped to the transcriptional co-repressor SKI, which is a negative regulator of TGF-β signaling that is rapidly degraded upon ligand stimulation. The molecular consequences of these mutations, however, are not understood. Here we use a combination of structural biology, genome editing, and biochemistry to show that SGS mutations in SKI abolish its binding to phosphorylated SMAD2 and SMAD3. This results in stabilization of SKI and consequently attenuation of TGF-β responses, both in knockin cells expressing an SGS mutation and in fibroblasts from SGS patients. Thus, we reveal that SGS is associated with an attenuation of TGF-β-induced transcriptional responses, and not enhancement, which has important implications for other Marfan-related syndromes.

#5

Health-related quality of life in Marfan syndrome: a 10-year follow-up.

Health and quality of life outcomes2020 Dec 01

Marfan syndrome, a rare hereditary connective tissue disorder caused by mutations in fibrillin-1, can affect many organ systems, especially the cardiovascular system. Previous research has paid less attention to health-related quality of life and prospective studies on this topic are needed. The aim of this study was to assess changes in health-related quality of life after 10 years in a Norwegian Marfan syndrome cohort. Forty-seven Marfan syndrome patients ≥ 18 years were investigated for all organ manifestations in the 1996 Ghent nosology and completed the self-reported questionnaire, Short-Form-36 Health Survey, at baseline in 2003-2004 and at follow-up in 2014-2015. Paired sample t tests were performed to compare means and multiple regression analyses were performed with age, sex, new cardiovascular and new non-cardiovascular pathology as predictors. At 10-year follow-up: a significant decline was found in the physical domain. The mental domain was unchanged. Older age predicted a larger decline in physical health-related quality of life. None of the chosen Marfan-related variables predicted changes in any of the subscales of the Short-Form 36 Health Survey or in the physical or the mental domain. Knowledge of decline in the physical domain, not related to organ affections, may be important in the follow-up of Marfan syndrome patients.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC2 artigos no totalmostrando 10

2026

Aortic dissection during the perinatal period in women with Marfan-related disorders: a retrospective cohort study using the Japanese Diagnosis Procedure Combination database.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
2024

Targeted next-generation sequencing reveals the genetic mechanism of Chinese Marfan syndrome cohort with ocular manifestation.

Molecular genetics & genomic medicine
2024

Three-dimensional co-culturing of stem cell-derived cardiomyocytes and cardiac fibroblasts reveals a role for both cell types in Marfan-related cardiomyopathy.

Matrix biology : journal of the International Society for Matrix Biology
2021

Mutations in SKI in Shprintzen-Goldberg syndrome lead to attenuated TGF-β responses through SKI stabilization.

eLife
2020

Health-related quality of life in Marfan syndrome: a 10-year follow-up.

Health and quality of life outcomes
2019

Novel FBN1 Heterozygous Mutations Identified in Chinese Families with Marfan Syndrome.

Annals of clinical and laboratory science
2019

Targeted deletion of fibrillin-1 in the mouse eye results in ectopia lentis and other ocular phenotypes associated with Marfan syndrome.

Disease models & mechanisms
2018

The phenotypic heterogeneity of patients with Marfan-related disorders and their variant spectrums.

Medicine
2015

Work participation in adults with Marfan syndrome: Demographic characteristics, MFS related health symptoms, chronic pain, and fatigue.

American journal of medical genetics. Part A
2015

DPY-17 and MUA-3 Interact for Connective Tissue-Like Tissue Integrity in Caenorhabditis elegans: A Model for Marfan Syndrome.

G3 (Bethesda, Md.)

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome Marfan e doenças Marfan-relacionadas.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome Marfan e doenças Marfan-relacionadas

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Aortic dissection during the perinatal period in women with Marfan-related disorders: a retrospective cohort study using the Japanese Diagnosis Procedure Combination database.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians· 2026· PMID 41866242mais citado
  2. Targeted next-generation sequencing reveals the genetic mechanism of Chinese Marfan syndrome cohort with ocular manifestation.
    Molecular genetics & genomic medicine· 2024· PMID 38958168mais citado
  3. Three-dimensional co-culturing of stem cell-derived cardiomyocytes and cardiac fibroblasts reveals a role for both cell types in Marfan-related cardiomyopathy.
    Matrix biology : journal of the International Society for Matrix Biology· 2024· PMID 38224822mais citado
  4. Mutations in SKI in Shprintzen-Goldberg syndrome lead to attenuated TGF-β responses through SKI stabilization.
    eLife· 2021· PMID 33416497mais citado
  5. Health-related quality of life in Marfan syndrome: a 10-year follow-up.
    Health and quality of life outcomes· 2020· PMID 33256748mais citado
  6. Mast cell mediators in hereditary angioedema.
    Orphanet J Rare Dis· 2026· PMID 41832580recente
  7. Prenatal Molecular Diagnosis of COL2A1-Associated Stickler Syndrome: Genotype-Phenotype Correlation in a Resource-Limited Healthcare Setting.
    Int J Mol Sci· 2026· PMID 41828453recente
  8. Platelet gene signatures detecting pulmonary artery stenosis in patients with pulmonary hypertension.
    Orphanet J Rare Dis· 2026· PMID 41827036recente
  9. The global impact of imiglucerase therapy in children with Gaucher disease types 1 and 3: a real-world analysis from the International Collaborative Gaucher Group Gaucher Registry.
    Orphanet J Rare Dis· 2026· PMID 41821052recente
  10. Monogenic lupus with SLC7A7 mutations: a retrospective study from a Chinese center.
    Orphanet J Rare Dis· 2026· PMID 41821046recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:284993(Orphanet)
  2. MONDO:0017310(MONDO)
  3. GARD:21129(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q6759035(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome Marfan e doenças Marfan-relacionadas
Compêndio · Raras BR

Síndrome Marfan e doenças Marfan-relacionadas

ORPHA:284993 · MONDO:0017310
Medicamentos
10 registrados
MedGen
UMLS
C0424617
EuropePMC
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades